Skip to main content
Caplight Logo









Hopewell Therapeutics

Hopewell Therapeutics

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://hopewell-tx.com

Last Round

Seed

Jun 7, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hopewell Therapeutics operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. It was founded in 2018.

Hopewell Therapeutics is a biotechnology company that develops tissue-targeted lipid nanoparticles (ttLNPs) for the systemic delivery of genomic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hopewell Therapeutics Comparables

Compare Hopewell Therapeutics with similar companies based on industry and business-model similarity.

Hopewell Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kamal Therapeutics, Inc.
89%
Genevant Sciences
83%
Mana.bio
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hopewell Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 7, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hopewell Therapeutics Investors

Notable investors and investment history

Hopewell Therapeutics investors
InvestorRounds
Hike CapitalSeed
Mass Ave CapitalSeed
5Y CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 95% MoM.

  • Jun 18, 2026

    Monthly visitors increased 42% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hopewell Therapeutics Filings

Explore SEC and related filing metadata, where available.

Hopewell Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hopewell Therapeutics's valuation, stock price, and market status.

Is Hopewell Therapeutics a public or private company?

Hopewell Therapeutics is a private company.

What is the current stock price of Hopewell Therapeutics?

Hopewell Therapeutics is a private company, so its shares have no public market price. Caplight tracks Hopewell Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hopewell Therapeutics worth (valuation)?

Valuation information for Hopewell Therapeutics is not publicly available.

Can I buy Hopewell Therapeutics stock?

Hopewell Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hopewell Therapeutics's last funding round?

Hopewell Therapeutics's most recent funding round was Seed on June 7, 2023.

Who are the main investors in Hopewell Therapeutics?

Key investors in Hopewell Therapeutics include Hike Capital, Mass Ave Capital, 5Y Capital.

Will Hopewell Therapeutics IPO soon?

No public IPO plans have been announced for Hopewell Therapeutics.

How can I track Hopewell Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Hopewell Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range5
Year Founded2018
Last FundingJun 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?